Amit Awasthi

Tweeting in my personal capacity. Immunologist, Cancer Immunotherapy, Autoimmunity, T cell differentiation. President, Indian Immunology Society (IIS)

[DBT-THSTI @THSTIFaridabad]

@THSTIFaridabad is excited to share that Prof. Amit Awasthi (@awa_amit) has been conferred as a Fellow of the Indian Academy of Sciences.
This prestigious honor recognizes his immense and critical contributions to understanding the complexities of the immune system. A proud moment for the entire scientific community!
@DBTIndia @BricDbt @rajesh_gokhale @drkarthik2010

[Amit Awasthi @awa_amit]

Thank you, Sun Pharma Foundation, for this recognition. I am deeply grateful to all my students, and research scholars for their invaluable contributions throughout this journey. My heartfelt thanks to my family, friends, and mentors for their unwavering support. @THSTIFaridabad

[Sun Pharma @SunPharma_Live]

We’re proud to celebrate the Sun Pharma Science Foundation Research Fellowship 2025 awardees — exceptional researchers shaping the future of healthcare and scientific discovery in India.

Congratulations to all the winners.

[DBT-THSTI @THSTIFaridabad]

🚨 A landmark paper for T cell researchers!

Since T cell subsets possess immense heterogeneity, having defined guidelines is critical. Leaders of the field came together to create this pivotal consensus statement.

Proud contribution by Dr. Amit Awasthi (@awa_amit) from @THSTIFaridabad to this global effort published in @NatRevImmunol.

🔗 https://t.co/Jy9dYZmNsc

#Immunology #healthcare #research

@DBTIndia @BricDbt @rajesh_gokhale @drkarthik2010

[DBT-THSTI @THSTIFaridabad]

🧵 1/2
Cell & Gene Therapy (CGT) capacity building in India! 🇮🇳
@THSTIFaridabad, @BIRAC_2012, and @miltenyibiotec successfully hosted a powerful symposia today, uniting clinicians, academics, and industry leaders.
Key focus: Developing indigenous CGT constructs and fostering an ecosystem where this multi-sector collaboration thrives.
Driving forward the advanced therapy ecosystem!
#CellandGeneTherapy #MakeInIndia #Biotechnology #Collaboration

[THREAD 👇]

[DBT-THSTI @THSTIFaridabad]

🧵 2/2

The momentum continues with a 3-day hands-on CAR-T manufacturing workshop (12-14 Nov 2025)!

This first-of-its-kind training blends Miltenyi University online modules with immersive practical sessions at THSTI's facility.
Participants get end-to-end exposure to CGT manufacturing, including:
Preclinical Development, Closed-System Cell Processing, Quality Control & Compliance

Upskilling the next generation of CGT pioneers!

#CARTherapy #Training #capacitybuilding #AdvancedTherapy

@DrJitendraSingh @DBTIndia @BricDbt @rajesh_gokhale @drkarthik2010 @awa_amit @miltenyibiotec

[DBT-THSTI @THSTIFaridabad]

👏Congratulations to Prof Amit Awasthi @awa_amit for receiving the award from Sun Pharma Science Foundation in Medical Sciences-Basic research category!
This award is in recognition of his impactful contributions to Immunology Research.
@DBTIndia @BricDbt @rajesh_gokhale @drkarthik2010

[DBT-THSTI @THSTIFaridabad]

Join us for a symposia and hands-on training workshop on CAR-T Cell Therapy Manufacturing at
@THSTIFaridabad from Nov 11-14, 2025. The workshop is in collaboration with @miltenyibiotec.
Visit the link for full details on the agenda, venue, and fees: 🔗https://t.co/sZBSr21GSH #CellTherapy #Symposium #Workshop #Biotechnology
@DBTIndia @BricDbt @rajesh_gokhale @drkarthik2010
@awa_amit

[Amit Awasthi @awa_amit]

I am grateful and humbled for this recognition @JM_Scindia @kiranshaw @CSIR_IND @DBTIndia @IndiaDST

[DBT-THSTI @THSTIFaridabad]

Congratulations to Prof Amit Awasthi @THSTIFaridabad on being elected as a Fellow of the National Academy of Sciences, India (NASI), the oldest Science Academy of India! This recognition comes for his significant contributions in the field of T-cell biology in inflammatory diseases and T-cell
immune response to COVID-19 vaccines.
@DrJitendraSingh @DBTIndia @rajes_gokhale @drkarthik2010 @awa_amit

[DBT-THSTI @THSTIFaridabad]

Thrilled to be driving this forward!
@THSTIFaridabad teams' expertise led by Prof Amit Awasthi @awa_amit is focused on making sure these advanced CAR-T therapies are not just groundbreaking but also affordable and accessible to the public. Quality is our priority, and accessibility our mission.
A big step for #AtmanirbharBharat in #CellandGeneTherapy.
@DrJitendraSingh @DBTIndia @BricDbt @rajesh_gokhale @drkarthik2010

[DBT-THSTI @THSTIFaridabad]

👉A new study reveals how testosterone suppresses Th17 cells, a key driver of skin inflammation. It binds to RORγt, inhibiting gene expression and reducing inflammation in a psoriasis model. This offers a new explanation for gender bias observed in organ-specific autoimmune diseases.
🔗https://t.co/MMaLwKXWDE
#Immunology #AutoimmuneDiseases
@DBTIndia @rajesh_gokhale @drkarthik2010 @awa_amit

[DBT-THSTI @THSTIFaridabad]

👏Dr. Rajdeep Dalal, Research Scientist @DalalRajde70860 working with Prof Amit Awasthi @awa_amit of @THSTIFaridabad, was honored as a "Young Investigator (Cross Asia Pacific) 2025" by the World Immunotherapy Council! He presented his work on 'Dietary Micronutrients and Microbiome Interactions in the Modulation of Cancer Immunity' in an event held at Singapore, July 21-22, 2025.
@DBTIndia @rajesh_gokhale @drkarthik2010

[DBT-THSTI @THSTIFaridabad]

📢Nature Index (India) 2024-25 rankings are out

iBRIC+ is ranked number 3 in the Health Sciences category and @THSTIFaridabad remains the premier institute for translational health science research in the country, contributing to more than half (5 out of 9) of the health sciences publications considered for the rankings.
🎉Congratulations to all the contributors!

@DrJitendraSingh @DBTIndia @rajesh_gokhale @drkarthik2010

[BioVoice News @BiovoiceNews]

BIO-PHARMA: @miltenyibiotec has signed a Letter of Intent with @THSTIFaridabad to establish India’s first hands-on training program in clinical cell manufacturing.

Click to read: https://t.co/mbOUepTH96

@DBTIndia @BIRAC_2012 #CGT #genetherapy #biopharma #biovoicenews

[Dr Jitendra Singh @DrJitendraSingh]

Did a walkthrough of the upcoming state-of-the-art, first-of-its-kind “Medical Research Centre” (MRC) at Translational Health Science & Technology Institute (THSTI), Faridabad — a flagship initiative supported by @DBTIndia.

This 50-bed facility will facilitate translational research, especially in early clinical trials, precision medicine and public health innovation.

It features South Asia’s first and one of Asia’s few Controlled Human Infection Study Centres, alongside cutting-edge Cell & Gene Therapy units, DMPK labs, and a world-class Biorepository.

Indeed, a milestone for India’s biotech and research ecosystem.
#ScienceForNewIndia

[Amit Awasthi @awa_amit]

@iuis_online Congratulations all!

[DBT-THSTI @THSTIFaridabad]

👏Dr. Srikanth Sadhu, Research Scientist at @THSTIFaridabad has been selected for the prestigious International Union of Immunological Societies (#IUIS2025) rising stars awards! #RisingStars2025
Dr. Sadhu will present his work at the 19th IUIS, taking place in Vienna, Austria, from August 17–22, 2025.
https://t.co/dfYxfkW6gY
@DBTIndia @rajesh_gokhale @drkarthik2010

[International Union of Immunological Societies @iuis_online]

IUIS and its Early Career Committee are thrilled to announce the IUIS #RisingStars2025 Cohort! 🌟
https://t.co/fyTP5KVp0y
Fifteen exceptional early-career scientists from across the globe to join our #RisingStars Program
Don’t miss your chance to meet them https://t.co/2u2uRU25fd

[Dr Jitendra Singh @DrJitendraSingh]

"Announced major policy reforms to enhance 'Ease of Innovation', 'Ease of Research' and 'Ease of Science'. Such pathbreaking decisions could not have been possible without the personal indulgence and support of PM @narendramodi .

Research Institutions allowed Non-GeM procurement for specialised equipment.

Directors, VCs to get greater autonomy in procurement. Financial ceilings relaxed.

This is a move that places trust in the science leaders of this country".

: Press Conference: National Media Centre, New Delhi.

[Department of Biotechnology @DBTIndia]

Researchers at the BRIC @THSTIFaridabad have shown that #colitis is associated with an increase in succinate-producing gut bacteria underscoring the role of #gut microbiota-derived succinate in driving colitogenic T cells and its potential as a therapeutic target for treating #IBD.

🖇️https://t.co/kmAuIADjui

@DrJitendraSingh @rajesh_gokhale @BricDbt7510

[Amit Awasthi @awa_amit]

Recent paper from our laboratory.

[The Colitist @colitist]

Gut commensals-derived succinate impels colonic inflammation in ulcerative colitis #IBD
https://t.co/XYk2sNmk7J